In vivo, PHKG2-overexpressing xenografts exhibited significantly smaller tumor volumes (Fig. 3H, I) and reduced Ki67 expression, even under TP53 inhibition (Fig. 3J). This evidence concerns the gene PHKG2 and neoplasm.